Novel nested patch-based feature extraction model for automated Parkinson's Disease symptom classification using MRI images

Impact of canny edge detection preprocessing on performance of machine learning models for Parkinson's disease classification

This study investigates the classification of individuals as healthy or at risk of Parkinson's disease using machine learning (ML) models, focusing on the impact of dataset size and preprocessing techniques on model performance. Four datasets are created from an original dataset: [Formula: see text] (normal dataset), [Formula: see text] ([Formula: see text] subjected to Canny edge detection and Hessian filtering), [Formula: see text] (augmented [Formula: see text]), and [Formula: see text] (augmented [Formula: see text]). We evaluate a range of ML models-Logistic Regression (LR), Decision Tree (DT), Random Forest (RF), Gradient Boosting (GB), XGBoost (XBG), Naive Bayes (NB), Support Vector Machine (SVM), and AdaBoost (AdB)-on these datasets, analyzing prediction accuracy, model size, and prediction latency. The results show that while larger datasets lead to increased model memory footprints and prediction latencies, the Canny edge detection preprocessing supplemented by Hessian filtering (used in [Formula: see text] and [Formula: see text]) degrades the performance of most models. In our experiment, we observe that Random Forest (RF) maintains a stable memory footprint of 61 KB across all datasets, while models like KNN and SVM show significant increases in memory usage, from 5.7-7 KB on [Formula: see text] to 102-220 KB on [Formula: see text], and similar increases in prediction time. Logistic Regression, Decision Tree, and Naive Bayes show stable memory footprints and fast prediction times across all datasets. XGBoost's prediction time increases from 180-200 ms on [Formula: see text] to 700-3000 ms on [Formula: see text]. Statistical analysis using the Mann-Whitney U test with 100 prediction accuracy observations per model (98 degrees of freedom) reveals significant differences in performance between models trained on [Formula: see text] and [Formula: see text] (p-values < 1e-34 for most models), while the effect sizes measured by estimating Cliff's delta values (approaching [Formula: see text]) indicate large shifts in performance, especially for SVM and XGBoost. These findings highlight the importance of selecting lightweight models like LR and DT for deployment in resource-constrained healthcare applications, as models like KNN, SVM, and XGBoost show significant increases in resource demands with larger datasets, particularly when Canny preprocessing is applied.

Bioinformatics-based modeling of lung squamous cell carcinoma prognosis and prediction of immunotherapy response

Lung squamous cell carcinoma (LUSC) is a subtype of non-small cell lung cancer. It has a grim prognosis for patients, primarily because the disease often remains asymptomatic in its early stages. As a result, it is frequently diagnosed at an advanced stage, limiting treatment options. This underscores the importance of studying potential biomarkers and developing personalized treatment strategies. In this study, we used an advanced bioinformatics approach, integrating two authoritative databases, NCBI's GEO and TCGA, to perform a large-scale cross-platform gene expression analysis. To deeply mine the gene expression data of a large number of lung squamous carcinoma samples, we used a screening strategy based on median absolute deviation to select genes that differed significantly in multiple datasets. The expression variations of these genes between normal and cancerous tissues provided us with valuable clues revealing key molecules that may be involved in the disease process. Through rigorous statistical tests, we identified 36 genes that were significantly associated with patient survival, and further constructed a model using Cox proportional risk model containing 11 key genes (MRPL40, GABPB1AS1, PTPN3, SNCA, PYGB, RAP1, VDR, PHPT1, KIAA0100, TBC1D30, CYP7B1) in a risk prediction model. The prediction model not only reflects the strong correlation between gene expression and LUSC prognosis, but also provides clinicians with an effective tool to predict patients' survival prospects. In the future, this model is expected to guide the development of individualized treatment plans, thereby improving the quality of life and overall prognosis of patients.

Houston, We Have AI Problem! Quality Issues with Neuroimaging-Based Artificial Intelligence in Parkinson's Disease: A Systematic Review

In recent years, many neuroimaging studies have applied artificial intelligence (AI) to facilitate existing challenges in Parkinson's disease (PD) diagnosis, prognosis, and intervention. The aim of this systematic review was to provide an overview of neuroimaging-based AI studies and to assess their methodological quality. A PubMed search yielded 810 studies, of which 244 that investigated the utility of neuroimaging-based AI for PD diagnosis, prognosis, or intervention were included. We systematically categorized studies by outcomes and rated them with respect to five minimal quality criteria (MQC) pertaining to data splitting, data leakage, model complexity, performance reporting, and indication of biological plausibility. We found that the majority of studies aimed to distinguish PD patients from healthy controls (54%) or atypical parkinsonian syndromes (25%), whereas prognostic or interventional studies were sparse. Only 20% of evaluated studies passed all five MQC, with data leakage, non-minimal model complexity, and reporting of biological plausibility as the primary factors for quality loss. Data leakage was associated with a significant inflation of accuracies. Very few studies employed external test sets (8%), where accuracy was significantly lower, and 19% of studies did not account for data imbalance. Adherence to MQC was low across all observed years and journal impact factors. This review outlines that AI has been applied to a wide variety of research questions pertaining to PD; however, the number of studies failing to pass the MQC is alarming. Therefore, we provide recommendations to enhance the interpretability, generalizability, and clinical utility of future AI applications using neuroimaging in PD. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

A survey of detection of Parkinson's disease using artificial intelligence models with multiple modalities and various data preprocessing techniques

Parkinson's disease (PD) is a neurodegenerative brain disorder that causes symptoms such as tremors, sleeplessness, behavioral problems, sensory abnormalities, and impaired mobility, according to the World Health Organization (WHO). Artificial intelligence, machine learning (ML), and deep learning (DL) have been used in recent studies (2015-2023) to improve PD diagnosis by categorizing patients and healthy controls based on similar clinical presentations. This study investigates several datasets, modalities, and data preprocessing techniques from the collected data. Issues are also addressed, with suggestions for future PD research involving subgrouping and connection analysis using magnetic resonance imaging (MRI), dopamine transporter scan (DaTscan), and single-photon emission computed tomography (SPECT) data. We have used different models like Convolutional Neural Network (CNN) and Gated Recurrent Unit (GRU) for detecting PD at an early stage. We have used the Parkinson's Progression Markers Initiative (PPMI) dataset 3D brain images and archived the 86.67%, 94.02%, accuracy of models, respectively.

Brain connectivity for subtypes of parkinson's disease using structural MRI

Objective. Delineating Parkinson's disease (PD) into distinct subtypes is a major challenge. Most studies use clinical symptoms to label PD subtypes while our work uses an imaging-based data-mining approach to subtype PD. Our study comprises two major objectives - firstly, subtyping Parkinson's patients based on grey matter information from structural magnetic resonance imaging scans of human brains; secondly, comparative structural brain connectivity analysis of PD subtypes derived from the former step.Approach. Source-based-morphometry decomposition was performed on 131 Parkinson's patients and 78 healthy controls from PPMI dataset, to derive at components (regions) with significance in disease and high effect size. The loading coefficients of significant components were thresholded for arriving at subtypes. Further, regional grey matter maps of subtype-specific subjects were separately parcellated and employed for construction of subtype-specific association matrices using Pearson correlation. These association matrices were binarized using sparsity threshold and leveraged for structural brain connectivity analysis using network metrics.Main results. Two distinct Parkinson's subtypes (namely A and B) were detected employing loadings of two components satisfying the selection criteria, and a third subtype (AB) was detected, common to these two components. Subtype A subjects were highly weighted in inferior, middle and superior frontal gyri while subtype B subjects in inferior, middle and superior temporal gyri. Network metrics analyses through permutation test revealed significant inter-subtype differences (p < 0.05) in clustering coefficient, local efficiency, participation coefficient and betweenness centrality. Moreover, hubs were obtained using betweenness centrality and mean network degree.Significance. MRI-based data-driven subtypes show frontal and temporal lobes playing a key role in PD. Graph theory-driven brain network analyses could untangle subtype-specific differences in structural brain connections showing differential network architecture. Replication of these initial results in other Parkinson's datasets may be explored in future. Clinical Relevance- Investigating structural brain connections in Parkinson's disease may provide subtype-specific treatment.

ASNET: A Novel AI Framework for Accurate Ankylosing Spondylitis Diagnosis from MRI

BACKGROUND

Ankylosing spondylitis (AS) is a chronic, painful, progressive disease usually seen in the spine. Traditional diagnostic methods have limitations in detecting the early stages of AS. The early diagnosis of AS can improve patients' quality of life. This study aims to diagnose AS with a pre-trained hybrid model using magnetic resonance imaging (MRI).

MATERIALS AND METHODS

In this research, we collected a new MRI dataset comprising three cases. Furthermore, we introduced a novel deep feature engineering model. Within this model, we utilized three renowned pretrained convolutional neural networks (CNNs): DenseNet201, ResNet50, and ShuffleNet. Through these pretrained CNNs, deep features were generated using the transfer learning approach. For each pretrained network, two feature vectors were generated from an MRI. Three feature selectors were employed during the feature selection phase, amplifying the number of features from 6 to 18 (calculated as 6 × 3). The k-nearest neighbors (kNN) classifier was utilized in the classification phase to determine classification results. During the information phase, the iterative majority voting (IMV) algorithm was applied to secure voted results, and our model selected the output with the highest classification accuracy. In this manner, we have introduced a self-organized deep feature engineering model.

RESULTS

We have applied the presented model to the collected dataset. The proposed method yielded 99.80%, 99.60%, 100%, and 99.80% results for accuracy, recall, precision, and F1-score for the collected axial images dataset. The collected coronal image dataset yielded 99.45%, 99.20%, 99.70%, and 99.45% results for accuracy, recall, precision, and F1-score, respectively. As for contrast-enhanced images, accuracy of 95.62%, recall of 80.72%, precision of 94.24%, and an F1-score of 86.96% were attained.

CONCLUSIONS

Based on the results, the proposed method for classifying AS disease has demonstrated successful outcomes using MRI. The model has been tested on three cases, and its consistently high classification performance across all cases underscores the model's general robustness. Furthermore, the ability to diagnose AS disease using only axial images, without the need for contrast-enhanced MRI, represents a significant advancement in both healthcare and economic terms.

Detection of Parkinson's disease from EEG signals using discrete wavelet transform, different entropy measures, and machine learning techniques

Early detection of Parkinson's disease (PD) is very important in clinical diagnosis for preventing disease development. In this study, we present efficient discrete wavelet transform (DWT)-based methods for detecting PD from health control (HC) in two cases, namely, off-and on-medication. First, the EEG signals are preprocessed to remove major artifacts before being decomposed into several EEG sub-bands (approximate and details) using DWT. The features are then extracted from the wavelet packet-derived reconstructed signals using different entropy measures, namely, log energy entropy, Shannon entropy, threshold entropy, sure entropy, and norm entropy. Several machine learning techniques are investigated to classify the resulting PD/HC features. The effects of DWT coefficients and brain regions on classification accuracy are being investigated as well. Two public datasets are used to verify the proposed methods: the SanDiego dataset (31 subjects, 93 min) and the UNM dataset (54 subjects, 54 min). The results are promising and show that four entropy measures: log energy entropy, threshold entropy, sure entropy, and modified-Shannon entropy (TShEn) lead to high classification accuracy, indicating they are good biomarkers for PD detection. With the SanDiego dataset, the classification results of off-medication PD versus HC are 99.89, 99.87, and 99.91 for accuracy, sensitivity, and specificity, respectively, using the combination of DWT + TShEn and KNN classifier. Using the same combination, the results of on-medication PD versus HC are 94.21, 93.33, and 95%. With the UNM dataset, the obtained classification accuracy is around 99.5% in both cases of off-and on-medication PD using DWT + TShEn + SVM and DWT + ThEn + KNN, respectively. The results also demonstrate the importance of all DWT coefficients and that selecting a suitable small number of EEG channels from several brain regions could improve the classification accuracy.

Automated detection of pain levels using deep feature extraction from shutter blinds-based dynamic-sized horizontal patches with facial images

Pain intensity classification using facial images is a challenging problem in computer vision research. This work proposed a patch and transfer learning-based model to classify various pain intensities using facial images. The input facial images were segmented into dynamic-sized horizontal patches or "shutter blinds". A lightweight deep network DarkNet19 pre-trained on ImageNet1K was used to generate deep features from the shutter blinds and the undivided resized segmented input facial image. The most discriminative features were selected from these deep features using iterative neighborhood component analysis, which were then fed to a standard shallow fine k-nearest neighbor classifier for classification using tenfold cross-validation. The proposed shutter blinds-based model was trained and tested on datasets derived from two public databases-University of Northern British Columbia-McMaster Shoulder Pain Expression Archive Database and Denver Intensity of Spontaneous Facial Action Database-which both comprised four pain intensity classes that had been labeled by human experts using validated facial action coding system methodology. Our shutter blinds-based classification model attained more than 95% overall accuracy rates on both datasets. The excellent performance suggests that the automated pain intensity classification model can be deployed to assist doctors in the non-verbal detection of pain using facial images in various situations (e.g., non-communicative patients or during surgery). This system can facilitate timely detection and management of pain.